|
JPS58110600A
(ja)
|
1981-12-25 |
1983-07-01 |
Kyowa Hakko Kogyo Co Ltd |
ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
|
|
JPS60221091A
(ja)
|
1983-12-21 |
1985-11-05 |
Kyowa Hakko Kogyo Co Ltd |
新規プロモ−タ−
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
JP2564268B2
(ja)
|
1985-08-28 |
1996-12-18 |
協和醗酵工業株式会社 |
融合抗原ポリペプチド
|
|
ZA872705B
(en)
|
1986-04-22 |
1987-10-05 |
Immunex Corporation |
Human g-csf protein expression
|
|
JP2928287B2
(ja)
|
1988-09-29 |
1999-08-03 |
協和醗酵工業株式会社 |
新規ポリペプチド
|
|
JPH02257891A
(ja)
|
1989-03-31 |
1990-10-18 |
Kyowa Hakko Kogyo Co Ltd |
組換え動物細胞による蛋白質の製造
|
|
JPH0322979A
(ja)
|
1989-06-19 |
1991-01-31 |
Kyowa Hakko Kogyo Co Ltd |
新規プラスミノーゲン活性化因子
|
|
JP3131322B2
(ja)
|
1991-12-17 |
2001-01-31 |
協和醗酵工業株式会社 |
新規α２→３シアリルトランスフェラーゼ
|
|
JP3756946B2
(ja)
|
1993-03-29 |
2006-03-22 |
協和醗酵工業株式会社 |
α１，３−フコシルトランスフェラーゼ
|
|
ES2233974T3
(es)
|
1995-09-11 |
2005-06-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
|
|
US6001358A
(en)
|
1995-11-07 |
1999-12-14 |
Idec Pharmaceuticals Corporation |
Humanized antibodies to human gp39, compositions containing thereof
|
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
|
US7112324B1
(en)
|
1998-04-21 |
2006-09-26 |
Micromet Ag |
CD 19×CD3 specific polypeptides and uses thereof
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
PL209392B1
(pl)
|
1999-01-15 |
2011-08-31 |
Genentech Inc |
Przeciwciało, komórka gospodarza, sposób wytwarzania przeciwciała oraz zastosowanie przeciwciała
|
|
CA2704600C
(en)
|
1999-04-09 |
2016-10-25 |
Kyowa Kirin Co., Ltd. |
A method for producing antibodies with increased adcc activity
|
|
CA2953239A1
(en)
|
2000-10-06 |
2002-04-18 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody composition-producing cell
|
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
|
US7262278B2
(en)
|
2001-10-15 |
2007-08-28 |
Kirin Beer Kabushiki Kaisha |
Anti-HLA-DR antibody
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
US20060235201A1
(en)
*
|
2003-02-06 |
2006-10-19 |
Roman Kischel |
Enduring T cell response
|
|
JPWO2005035586A1
(ja)
|
2003-10-08 |
2007-11-22 |
協和醗酵工業株式会社 |
融合蛋白質組成物
|
|
EP1810979B1
(en)
|
2004-09-22 |
2012-06-20 |
Kyowa Hakko Kirin Co., Ltd. |
STABILIZED HUMAN IgG4 ANTIBODIES
|
|
US7923538B2
(en)
|
2005-07-22 |
2011-04-12 |
Kyowa Hakko Kirin Co., Ltd |
Recombinant antibody composition
|
|
EP2352765B1
(en)
|
2008-10-01 |
2018-01-03 |
Amgen Research (Munich) GmbH |
Cross-species-specific single domain bispecific single chain antibody
|
|
US8530629B2
(en)
*
|
2009-01-30 |
2013-09-10 |
Ab Biosciences, Inc. |
Lowered affinity antibodies and uses therefor
|
|
ES2697535T3
(es)
|
2009-06-11 |
2019-01-24 |
Inter Univ Research Institute Corporation Research Organization Of Information And Systems |
Procedimiento para la producción de proteína
|
|
WO2011028952A1
(en)
|
2009-09-02 |
2011-03-10 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
KR101423820B1
(ko)
*
|
2011-05-18 |
2014-07-30 |
한화케미칼 주식회사 |
개선된 항암활성을 가지는 신규한 양특이성 단일클론 항체 및 이를 포함하는 암치료용 조성물
|
|
US9714291B2
(en)
*
|
2012-10-05 |
2017-07-25 |
Kyowa Hakko Kirin Co., Ltd |
Heterodimer protein composition
|
|
US11634502B2
(en)
|
2013-03-15 |
2023-04-25 |
Amgen Inc. |
Heterodimeric bispecific antibodies
|
|
US20160257748A1
(en)
|
2013-09-25 |
2016-09-08 |
Amgen Inc. |
V-c-fc-v-c antibody
|
|
JP2016538275A
(ja)
|
2013-11-04 |
2016-12-08 |
グレンマーク ファーマシューティカルズ， エセ．アー． |
Ｔ細胞再標的化ヘテロ二量体免疫グロブリン（ｈｅｔｅｒｏ−ｄｉｍｅｒｉｃ ｉｍｍｕｎｏｇｌｏｂｕｌｉｎ）の製造
|
|
IL263466B2
(en)
*
|
2013-12-17 |
2023-10-01 |
Genentech Inc |
Anti-CD3 antibodies and methods of using them
|
|
CA2955947A1
(en)
*
|
2014-07-25 |
2016-01-28 |
Cytomx Therapeutics, Inc. |
Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same
|
|
EP2982693A1
(en)
*
|
2014-08-07 |
2016-02-10 |
Affimed Therapeutics AG |
CD3 binding domain
|
|
JPWO2016111344A1
(ja)
*
|
2015-01-08 |
2017-10-26 |
協和発酵キリン株式会社 |
Ｔｒａｉｌｒ２とｐｓｍａに結合するバイスペシフィック抗体
|
|
MX2018005232A
(es)
*
|
2015-11-03 |
2018-08-15 |
Ambrx Inc |
Anticuerpos anti-cd3 novedosos y sus usos.
|
|
WO2017124002A1
(en)
*
|
2016-01-13 |
2017-07-20 |
Compass Therapeutics Llc |
Multispecific immunomodulatory antigen-binding constructs
|
|
WO2017210443A1
(en)
|
2016-06-01 |
2017-12-07 |
Xencor, Inc. |
Bispecific antibodies that bind cd123 and cd3
|
|
WO2018237364A1
(en)
*
|
2017-06-22 |
2018-12-27 |
Development Center For Biotechnology |
Asymmetric heterodimeric fc-scfv fusion anti-globo h and anti-cd3 bispecifc antibody and uses thereof in caner therapy
|
|
EP3645050A4
(en)
*
|
2017-06-25 |
2021-08-11 |
Systimmune, Inc. |
Multi-specific antibodies and methods of making and using thereof
|
|
US11912775B2
(en)
|
2017-07-18 |
2024-02-27 |
Kyowa Kirin Co., Ltd. |
Anti-human CCR1 monoclonal antibody
|